Pleural effusion related to IgG4

por Murata, Yoriyuki, Aoe, Keisuke, Mimura, Yusuke
Publicado 2019

Clinical Significance of Soluble CD26 in Malignant Pleural Mesothelioma

por Fujimoto, Nobukazu, Ohnuma, Kei, Aoe, Keisuke, Hosono, Osamu, Yamada, Taketo, Kishimoto, Takumi, Morimoto, Chikao
Publicado 2014

Benefits of a Nationwide Palliative Care Education Program on Lung Cancer Physicians

por Inoue, Akira, Yamaguchi, Takuhiro, Tanaka, Keiko, Sakashita, Akihiro, Aoe, Keisuke, Seki, Nobuhiko, Hagiwara, Koichi
Publicado 2019

Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective Analysis

por Oishi, Keiji, Aoe, Keisuke, Mimura, Yusuke, Murata, Yoriyuki, Sakamoto, Kenji, Koutoku, Wataru, Matsumoto, Tsuneo, Ueoka, Hiroshi, Yano, Masafumi
Publicado 2016

Quality of life of survivors of malignant pleural mesothelioma in Japan: a cross sectional study

por Nagamatsu, Yasuko, Oze, Isao, Aoe, Keisuke, Hotta, Katsuyuki, Kato, Katsuya, Nakagawa, Junko, Hara, Keiko, Kishimoto, Takumi, Fujimoto, Nobukazu
Publicado 2018

Physician requests by patients with malignant pleural mesothelioma in Japan

por Nagamatsu, Yasuko, Oze, Isao, Aoe, Keisuke, Hotta, Katsuyuki, Kato, Katsuya, Nakagawa, Junko, Hara, Keiko, Kishimoto, Takumi, Fujimoto, Nobukazu
Publicado 2019

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma

por Miyamoto, Yosuke, Kozuki, Toshiyuki, Aoe, Keisuke, Wada, Sae, Harada, Daijiro, Yoshida, Michihiro, Sakurai, Jun, Hotta, Katsuyuki, Fujimoto, Nobukazu
Publicado 2021

CD9 expression as a favorable prognostic marker for patients with malignant mesothelioma

por AMATYA, VISHWA JEET, TAKESHIMA, YUKIO, AOE, KEISUKE, FUJIMOTO, NOBUKAZU, OKAMOTO, TOSHIHIRO, YAMADA, TAKETO, KISHIMOTO, TAKUMI, MORIMOTO, CHIKAO, INAI, KOUKI
Publicado 2012

Clinical Investigation of Benign Asbestos Pleural Effusion

por Fujimoto, Nobukazu, Gemba, Kenichi, Aoe, Keisuke, Kato, Katsuya, Yokoyama, Takako, Usami, Ikuji, Onishi, Kazuo, Mizuhashi, Keiichi, Yusa, Toshikazu, Kishimoto, Takumi
Publicado 2015

Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study

por Seto, Takashi, Ohashi, Kadoaki, Sugawara, Shunichi, Nishio, Makoto, Takeda, Masayuki, Aoe, Keisuke, Moizumi, Sanae, Nomura, Satoshi, Tajima, Takeshi, Hida, Toyoaki
Publicado 2021

Monitoring EGFR T790M with plasma DNA from lung cancer patients in a prospective observational study

por Sueoka‐Aragane, Naoko, Katakami, Nobuyuki, Satouchi, Miyako, Yokota, Soichiro, Aoe, Keisuke, Iwanaga, Kentaro, Otsuka, Kojiro, Morita, Satoshi, Kimura, Shinya, Negoro, Shunichi
Publicado 2016

Clinical Efficacy and Safety of Nivolumab in Japanese Patients With Malignant Pleural Mesothelioma: 3-Year Results of the MERIT Study

por Fujimoto, Nobukazu, Okada, Morihito, Kijima, Takashi, Aoe, Keisuke, Kato, Terufumi, Nakagawa, Kazuhiko, Takeda, Yuichiro, Hida, Toyoaki, Kanai, Kuninobu, Hirano, Jun, Ohe, Yuichiro
Publicado 2020

Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial

por Takayama, Koichi, Katakami, Nobuyuki, Yokoyama, Takuma, Atagi, Shinji, Yoshimori, Kozo, Kagamu, Hiroshi, Saito, Hiroshi, Takiguchi, Yuichi, Aoe, Keisuke, Koyama, Akira, Komura, Naoyuki, Eguchi, Kenji
Publicado 2016

Health Care Resource Use Among Patients with Advanced Non–Small Cell Lung Cancer in Japan, 2017–2019

por Goto, Yasushi, Kawamura, Kodai, Fukuhara, Tatsuro, Namba, Yukiko, Aoe, Keisuke, Shukuya, Takehito, Tsuda, Takeshi, Santorelli, Melissa L., Taniguchi, Kazuko, Kamitani, Tetsu, Irisawa, Masato, Kanda, Kingo, Abe, Machiko, Burke, Thomas, Nokihara, Hiroshi
Publicado 2023

Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma

por Sato, Hiroki, Sakaguchi, Masakiyo, Yamamoto, Hiromasa, Tomida, Shuta, Aoe, Keisuke, Shien, Kazuhiko, Yoshioka, Takahiro, Namba, Kei, Torigoe, Hidejiro, Soh, Junichi, Tsukuda, Kazunori, Tao, Hiroyuki, Okabe, Kazunori, Miyoshi, Shinichiro, Pass, Harvey I., Toyooka, Shinichi
Publicado 2018

Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of...

por Katakami, Nobuyuki, Uchino, Junji, Yokoyama, Takuma, Naito, Tateaki, Kondo, Masashi, Yamada, Kouzo, Kitajima, Hiromoto, Yoshimori, Kozo, Sato, Kazuhiro, Saito, Hiroshi, Aoe, Keisuke, Tsuji, Tetsuya, Takiguchi, Yuichi, Takayama, Koichi, Komura, Naoyuki, Takiguchi, Toru, Eguchi, Kenji
Publicado 2017

Phase 2 Study of YS110, a Recombinant Humanized Anti-CD26 Monoclonal Antibody, in Japanese Patients With Advanced Malignant Pleural Mesothelioma

por Nakagawa, Kazuhiko, Kijima, Takashi, Okada, Morihito, Morise, Masahiro, Kato, Motoyasu, Hirano, Katsuya, Fujimoto, Nobukazu, Takenoyama, Mitsuhiro, Yokouchi, Hiroshi, Ohe, Yuichiro, Hida, Toyoaki, Aoe, Keisuke, Kishimoto, Takumi, Hirokawa, Masato, Matsuki, Hironori, Kaneko, Yutaro, Yamada, Taketo, Morimoto, Chikao, Takeda, Masayuki
Publicado 2021

Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung...

por Takayama, Koichi, Atagi, Shinji, Imamura, Fumio, Tanaka, Hiroshi, Minato, Koichi, Harada, Toshiyuki, Katakami, Nobuyuki, Yokoyama, Takuma, Yoshimori, Kozo, Takiguchi, Yuichi, Hataji, Osamu, Takeda, Yuichiro, Aoe, Keisuke, Kim, Young Hak, Yokota, Soichiro, Tabeta, Hiroshi, Tomii, Keisuke, Ohashi, Yasuo, Eguchi, Kenji, Watanabe, Koshiro
Publicado 2016

Nivolumab treatment of elderly Japanese patients with non-small cell lung cancer: subanalysis of a real-world retrospective observational study (CA209-9CR)

por Okishio, Kyoichi, Morita, Ryo, Shimizu, Junichi, Saito, Haruhiro, Sakai, Hiroshi, Kim, Young Hak, Hataji, Osamu, Yomota, Makiko, Nishio, Makoto, Aoe, Keisuke, Kanai, Osamu, Kumagai, Toru, Kibata, Kayoko, Tsukamoto, Hiroaki, Oizumi, Satoshi, Fujimoto, Daichi, Tanaka, Hiroshi, Mizuno, Keiko, Masuda, Takeshi, Kozuki, Toshiyuki, Haku, Takashi, Suzuki, Hiroyuki, Okamoto, Isamu, Hoshiyama, Hirotoshi, Yada, Nobumichi, Ohe, Yuichiro
Publicado 2020

First‐line pembrolizumab vs chemotherapy in metastatic non‐small‐cell lung cancer: KEYNOTE‐024 Japan subset

por Satouchi, Miyako, Nosaki, Kaname, Takahashi, Toshiaki, Nakagawa, Kazuhiko, Aoe, Keisuke, Kurata, Takayasu, Sekine, Akimasa, Horiike, Atsushi, Fukuhara, Tatsuro, Sugawara, Shunichi, Umemura, Shigeki, Saka, Hideo, Okamoto, Isamu, Yamamoto, Nobuyuki, Sakai, Hiroshi, Kishi, Kazuma, Katakami, Nobuyuki, Horinouchi, Hidehito, Hida, Toyoaki, Okamoto, Hiroaki, Atagi, Shinji, Ohira, Tatsuo, Han, Shi Rong, Noguchi, Kazuo, Ebiana, Victoria, Hotta, Katsuyuki
Publicado 2020